Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Dolutegravir price trend?

See the DrugPatentWatch profile for Dolutegravir

How has the price of dolutegravir changed over time?

I don’t have any price-history data for dolutegravir in the provided material, so I can’t describe a real-world “price trend” (for example, whether list prices or net prices have risen or fallen year to year).

Are you asking about list price, program price, or market price?

Dolutegravir prices can differ a lot depending on what’s being tracked:
- US “list price” versus discounted “net price” after rebates.
- Public-sector procurement (often lower) versus private-market pharmacy pricing.
- Single-ingredient tablets versus fixed-dose combinations (FDCs), which can have different pricing.

If you tell me which geography and which pricing basis you mean, I can help interpret what a “trend” would look like and what to watch.

What factors usually drive dolutegravir price moves?

Without specific numbers, the main drivers that typically affect trends for antiretrovirals include:
- Patent and exclusivity timelines (brand vs generic availability).
- Entry of additional generic manufacturers.
- Procurement policy changes and tender outcomes in public programs.
- Currency swings and supply constraints.
- Switching of guidelines that changes demand mix (e.g., move toward FDCs).

Does the dolutegravir form change the price trend?

Yes. A “dolutegravir price trend” can look different depending on whether you track:
- Dolutegravir alone (less common for routine prescribing than combinations in many settings)
- Common fixed-dose combinations (for example, dolutegravir-based regimens), which can be priced and procured differently than the standalone drug

Quick clarifying questions (so I can give the right trend)

1) Which country/region’s pricing do you want (US, EU, UK, South Africa, global/WHO, etc.)?
2) Do you want list price or a public-sector/procurement price?
3) Are you tracking dolutegravir as a single drug or a specific fixed-dose combination (and which strength)?
4) What time window counts as “trend” for you (last 12 months, 3 years, since generic entry, etc.)?

If you answer those, I can produce a focused trend description tailored to your use case (policy, market research, or procurement).



Other Questions About Dolutegravir :

tivicay dolutegravir active ingredient Dolutegravir patent expiry? Dolutegravir rilpivirine cost?